VIM and pancreatic neoplasm: Acquisition of gemcitabine-resistant phenotype of pancreatic cancer cells is accompanied by the elevated notch activity, whose silencing by siRNA attenuates the EMT phenotype such as vimentin, ZEB1, Slug, and Snail expression (Wang et al., 2009).